Replies to post #57687 on Ariad Pharmaceuticals Inc fka ARIA

[lax20m]

I'm not inferring that its bad news. All I'm saying is that if they want to alleviate cash concerns disclosing some terms of the milestones, if possible, would be good. For example, how much on approval? Is it 10M or is it 50M? If you remember they did this in the RIDA agreement. We knew what the early milestone amounts were. Not every milestone was disclosed but certainly amounts upon initial approval. Again, if the terms are good and the milestones that would occur sooner rather than later are significant, it behooves them to let the investing public know more details. The projected cash balance is a major focus item for ARIAD